Track Keynote: GLP-1's Lasting Impact on Consumer Preferences

Here’s the skinny: The global GLP-1 market is expected to grow to $200 billion by 2031, and the drug's current adoption is already being felt by retailers and consumer brands. Health-conscious consumers who leverage GLP-1 medications for weight management and improving their overall wellness are shifting their actions in the aisles by opting for smaller portions and seeking healthier alternatives. This Track Keynote will address GLP1's impact on grocery and how a large food and beverage company adapts to shoppers’ preferences for less food consumption and more nutritious offerings.

Monday 29 September 10:40 AM - 11:20 AM Unbottled Stage